1. Home
  2. ARRY vs IVA Comparison

ARRY vs IVA Comparison

Compare ARRY & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Array Technologies Inc.

ARRY

Array Technologies Inc.

HOLD

Current Price

$8.15

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.33

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARRY
IVA
Founded
1989
2011
Country
United States
France
Employees
N/A
77
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ARRY
IVA
Price
$8.15
$5.33
Analyst Decision
Buy
Strong Buy
Analyst Count
19
10
Target Price
$10.21
$16.20
AVG Volume (30 Days)
4.3M
475.1K
Earning Date
05-06-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
62.56
N/A
EPS
N/A
N/A
Revenue
$1,284,141,000.00
N/A
Revenue This Year
$15.72
N/A
Revenue Next Year
$8.08
$751.20
P/E Ratio
N/A
N/A
Revenue Growth
40.22
N/A
52 Week Low
$4.45
$2.94
52 Week High
$12.23
$7.98

Technical Indicators

Market Signals
Indicator
ARRY
IVA
Relative Strength Index (RSI) 58.70 42.42
Support Level $7.63 $5.04
Resistance Level $9.75 $6.42
Average True Range (ATR) 0.39 0.30
MACD 0.16 0.01
Stochastic Oscillator 85.75 41.95

Price Performance

Historical Comparison
ARRY
IVA

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that moves solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil, and the rest of the world, with the United States deriving the majority of the revenue.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: